Logo image of AED.BR

AEDIFICA (AED.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:AED - BE0003851681 - REIT

73.25 EUR
+0.1 (+0.14%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, AED scores 4 out of 10 in our fundamental rating. AED was compared to 42 industry peers in the Diversified REITs industry. AED has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, AED is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AED had positive earnings in the past year.
In the past year AED had a positive cash flow from operations.
In the past 5 years AED has always been profitable.
AED had a positive operating cash flow in each of the past 5 years.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

AED has a Return On Assets (2.73%) which is in line with its industry peers.
The Return On Equity of AED (4.96%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 3.52%, AED perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
AED had an Average Return On Invested Capital over the past 3 years of 3.33%. This is in line with the industry average of 3.45%.
The last Return On Invested Capital (3.52%) for AED is above the 3 year average (3.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AED's Profit Margin of 49.82% is fine compared to the rest of the industry. AED outperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of AED has declined.
AED's Operating Margin of 77.70% is fine compared to the rest of the industry. AED outperforms 71.43% of its industry peers.
AED's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 97.93%, AED belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

AED has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AED remains at a similar level compared to 1 year ago.
Compared to 5 years ago, AED has more shares outstanding
The debt/assets ratio for AED is higher compared to a year ago.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

AED has an Altman-Z score of 0.88. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
AED has a Altman-Z score of 0.88. This is comparable to the rest of the industry: AED outperforms 52.38% of its industry peers.
The Debt to FCF ratio of AED is 24.91, which is on the high side as it means it would take AED, 24.91 years of fcf income to pay off all of its debts.
AED's Debt to FCF ratio of 24.91 is on the low side compared to the rest of the industry. AED is outperformed by 69.05% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
AED has a Debt to Equity ratio of 0.58. This is in the better half of the industry: AED outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.88
ROIC/WACC0.57
WACC6.14%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AED (0.35) is comparable to the rest of the industry.
AED has a Quick Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.35, AED perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

AED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.94%, which is quite impressive.
AED shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.20% yearly.
AED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.06%.
Measured over the past years, AED shows a very strong growth in Revenue. The Revenue has been growing by 23.35% on average per year.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.18% yearly.
AED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.12% yearly.
EPS Next Y3.53%
EPS Next 2Y3.21%
EPS Next 3Y3.18%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.29, which indicates a correct valuation of AED.
The rest of the industry has a similar Price/Earnings ratio as AED.
Compared to an average S&P500 Price/Earnings ratio of 27.19, AED is valued a bit cheaper.
AED is valuated correctly with a Price/Forward Earnings ratio of 13.97.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AED indicates a slightly more expensive valuation: AED is more expensive than 66.67% of the companies listed in the same industry.
AED is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.29
Fwd PE 13.97
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AED's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AED is more expensive than 64.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AED is valued more expensive than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.61
EV/EBITDA 21.65
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)4.33
PEG (5Y)N/A
EPS Next 2Y3.21%
EPS Next 3Y3.18%

3

5. Dividend

5.1 Amount

AED has a Yearly Dividend Yield of 3.83%.
AED's Dividend Yield is slightly below the industry average, which is at 4.99.
Compared to an average S&P500 Dividend Yield of 1.92, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.83%

5.2 History

The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

AED pays out 105.58% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.21%
EPS Next 3Y3.18%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (1/9/2026, 7:00:00 PM)

73.25

+0.1 (+0.14%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-28 2025-10-28
Earnings (Next)02-17 2026-02-17/amc
Inst Owners41.34%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.48B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts81.11
Price Target76.58 (4.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.83%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.4%
PT rev (3m)2.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 15.29
Fwd PE 13.97
P/S 9.87
P/FCF 33.61
P/OCF 11.93
P/B 0.98
P/tB 1.01
EV/EBITDA 21.65
EPS(TTM)4.79
EY6.54%
EPS(NY)5.24
Fwd EY7.16%
FCF(TTM)2.18
FCFY2.98%
OCF(TTM)6.14
OCFY8.38%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)4.33
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.88
F-Score7
WACC6.14%
ROIC/WACC0.57
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y3.53%
EPS Next 2Y3.21%
EPS Next 3Y3.18%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.51%
EBIT Next 3Y6.39%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 15.29 and the Price/Book (PB) ratio is 0.98.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.